お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書はアデノシンデアミナーゼ欠損症市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはアデノシンデアミナーゼ欠損症の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界のアデノシンデアミナーゼ欠損症市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはアデノシンデアミナーゼ欠損症のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にアデノシンデアミナーゼ欠損症市場を分類しています。本研究に含まれる主な企業は：Leadiant Biosciences、Chiesi

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Adagen
    Revcovi

用途別の市場セグメント：
    Hospital
    Pharmacy

本レポートの詳細内容
世界のアデノシンデアミナーゼ欠損症市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、アデノシンデアミナーゼ欠損症タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のアデノシンデアミナーゼ欠損症収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のアデノシンデアミナーゼ欠損症市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、アデノシンデアミナーゼ欠損症市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

アデノシンデアミナーゼ欠損症のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：アデノシンデアミナーゼ欠損症のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：アデノシンデアミナーゼ欠損症の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章アデノシンデアミナーゼ欠損症企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：アデノシンデアミナーゼ欠損症の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：アデノシンデアミナーゼ欠損症の主要企業の概要を提供し、製品の説明と仕様、アデノシンデアミナーゼ欠損症の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births worldwide.
Market Analysis and Insights: Global Adenosine Deaminase Deficiency Market
The global Adenosine Deaminase Deficiency market is projected to grow from US$ 136 million in 2024 to US$ 174.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period.
The market driver for Adenosine Deaminase Deficiency (ADA) therapeutic products is the critical need to address this rare and life-threatening genetic disorder. ADA-SCID severely compromises the immune system, making effective treatment essential. Gene therapies and enzyme replacement therapies have shown promise in restoring immune function, driving market growth. However, challenges include limited patient population, high treatment costs, and the need for early and accurate diagnosis. Additionally, access to these specialized therapies and regulatory hurdles pose challenges. Despite challenges, the ADA therapeutic market presents opportunities for further research and development, offering hope for improved outcomes for patients with this devastating condition.
Report Covers:
This report presents an overview of global market for Adenosine Deaminase Deficiency market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Adenosine Deaminase Deficiency, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Adenosine Deaminase Deficiency, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Adenosine Deaminase Deficiency revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Adenosine Deaminase Deficiency market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Adenosine Deaminase Deficiency revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Leadiant Biosciences and Chiesi etc.

Market Segmentation
By Company
    Leadiant Biosciences
    Chiesi

Segment by Type
    Adagen
    Revcovi

Segment by Application
    Hospital
    Pharmacy

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Adenosine Deaminase Deficiency in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adenosine Deaminase Deficiency companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Adenosine Deaminase Deficiency revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Adenosine Deaminase Deficiency Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Adagen
    Table 3. Key Players of Revcovi
    Table 4. Global Adenosine Deaminase Deficiency Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Adenosine Deaminase Deficiency Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Adenosine Deaminase Deficiency Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Adenosine Deaminase Deficiency Market Share by Region (2019-2024)
    Table 8. Global Adenosine Deaminase Deficiency Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Adenosine Deaminase Deficiency Market Share by Region (2025-2030)
    Table 10. Adenosine Deaminase Deficiency Market Trends
    Table 11. Adenosine Deaminase Deficiency Market Drivers
    Table 12. Adenosine Deaminase Deficiency Market Challenges
    Table 13. Adenosine Deaminase Deficiency Market Restraints
    Table 14. Global Adenosine Deaminase Deficiency Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Adenosine Deaminase Deficiency Revenue Share by Players (2019-2024)
    Table 16. Global Top Adenosine Deaminase Deficiency by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adenosine Deaminase Deficiency as of 2023)
    Table 17. Global Adenosine Deaminase Deficiency Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Adenosine Deaminase Deficiency Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Adenosine Deaminase Deficiency, Headquarters and Area Served
    Table 20. Global Key Players of Adenosine Deaminase Deficiency, Product and Application
    Table 21. Global Key Players of Adenosine Deaminase Deficiency, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Adenosine Deaminase Deficiency Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Adenosine Deaminase Deficiency Revenue Market Share by Type (2019-2024)
    Table 25. Global Adenosine Deaminase Deficiency Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Adenosine Deaminase Deficiency Revenue Market Share by Type (2025-2030)
    Table 27. Global Adenosine Deaminase Deficiency Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Adenosine Deaminase Deficiency Revenue Share by Application (2019-2024)
    Table 29. Global Adenosine Deaminase Deficiency Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Adenosine Deaminase Deficiency Revenue Share by Application (2025-2030)
    Table 31. North America Adenosine Deaminase Deficiency Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Adenosine Deaminase Deficiency Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Adenosine Deaminase Deficiency Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Adenosine Deaminase Deficiency Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Adenosine Deaminase Deficiency Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Adenosine Deaminase Deficiency Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Adenosine Deaminase Deficiency Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Adenosine Deaminase Deficiency Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Adenosine Deaminase Deficiency Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Adenosine Deaminase Deficiency Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Adenosine Deaminase Deficiency Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Adenosine Deaminase Deficiency Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Adenosine Deaminase Deficiency Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Adenosine Deaminase Deficiency Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Adenosine Deaminase Deficiency Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Adenosine Deaminase Deficiency Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Adenosine Deaminase Deficiency Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Adenosine Deaminase Deficiency Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Adenosine Deaminase Deficiency Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Adenosine Deaminase Deficiency Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Adenosine Deaminase Deficiency Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Adenosine Deaminase Deficiency Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Adenosine Deaminase Deficiency Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Adenosine Deaminase Deficiency Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Adenosine Deaminase Deficiency Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Leadiant Biosciences Company Details
    Table 64. Leadiant Biosciences Business Overview
    Table 65. Leadiant Biosciences Adenosine Deaminase Deficiency Product
    Table 66. Leadiant Biosciences Revenue in Adenosine Deaminase Deficiency Business (2019-2024) & (US$ Million)
    Table 67. Leadiant Biosciences Recent Developments
    Table 68. Chiesi Company Details
    Table 69. Chiesi Business Overview
    Table 70. Chiesi Adenosine Deaminase Deficiency Product
    Table 71. Chiesi Revenue in Adenosine Deaminase Deficiency Business (2019-2024) & (US$ Million)
    Table 72. Chiesi Recent Developments
    Table 73. Research Programs/Design for This Report
    Table 74. Key Data Information from Secondary Sources
    Table 75. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Adenosine Deaminase Deficiency Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Adenosine Deaminase Deficiency Market Share by Type: 2023 VS 2030
    Figure 3. Adagen Features
    Figure 4. Revcovi Features
    Figure 5. Global Adenosine Deaminase Deficiency Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Adenosine Deaminase Deficiency Market Share by Application: 2023 VS 2030
    Figure 7. Hospital Case Studies
    Figure 8. Pharmacy Case Studies
    Figure 9. Adenosine Deaminase Deficiency Report Years Considered
    Figure 10. Global Adenosine Deaminase Deficiency Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 11. Global Adenosine Deaminase Deficiency Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Adenosine Deaminase Deficiency Market Share by Region: 2023 VS 2030
    Figure 13. Global Adenosine Deaminase Deficiency Market Share by Players in 2023
    Figure 14. Global Top Adenosine Deaminase Deficiency Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adenosine Deaminase Deficiency as of 2023)
    Figure 15. The Top 10 and 5 Players Market Share by Adenosine Deaminase Deficiency Revenue in 2023
    Figure 16. North America Adenosine Deaminase Deficiency Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 17. North America Adenosine Deaminase Deficiency Market Share by Type (2019-2030)
    Figure 18. North America Adenosine Deaminase Deficiency Market Share by Application (2019-2030)
    Figure 19. North America Adenosine Deaminase Deficiency Market Share by Country (2019-2030)
    Figure 20. United States Adenosine Deaminase Deficiency Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada Adenosine Deaminase Deficiency Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Adenosine Deaminase Deficiency Market Size YoY (2019-2030) & (US$ Million)
    Figure 23. Europe Adenosine Deaminase Deficiency Market Share by Type (2019-2030)
    Figure 24. Europe Adenosine Deaminase Deficiency Market Share by Application (2019-2030)
    Figure 25. Europe Adenosine Deaminase Deficiency Market Share by Country (2019-2030)
    Figure 26. Germany Adenosine Deaminase Deficiency Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France Adenosine Deaminase Deficiency Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. Adenosine Deaminase Deficiency Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy Adenosine Deaminase Deficiency Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia Adenosine Deaminase Deficiency Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries Adenosine Deaminase Deficiency Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. China Adenosine Deaminase Deficiency Market Size YoY (2019-2030) & (US$ Million)
    Figure 33. China Adenosine Deaminase Deficiency Market Share by Type (2019-2030)
    Figure 34. China Adenosine Deaminase Deficiency Market Share by Application (2019-2030)
    Figure 35. Asia Adenosine Deaminase Deficiency Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. Asia Adenosine Deaminase Deficiency Market Share by Type (2019-2030)
    Figure 37. Asia Adenosine Deaminase Deficiency Market Share by Application (2019-2030)
    Figure 38. Asia Adenosine Deaminase Deficiency Market Share by Region (2019-2030)
    Figure 39. Japan Adenosine Deaminase Deficiency Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. South Korea Adenosine Deaminase Deficiency Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. China Taiwan Adenosine Deaminase Deficiency Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Southeast Asia Adenosine Deaminase Deficiency Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. India Adenosine Deaminase Deficiency Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Australia Adenosine Deaminase Deficiency Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size YoY (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Share by Type (2019-2030)
    Figure 47. Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Share by Application (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Share by Country (2019-2030)
    Figure 49. Brazil Adenosine Deaminase Deficiency Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Mexico Adenosine Deaminase Deficiency Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Turkey Adenosine Deaminase Deficiency Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Adenosine Deaminase Deficiency Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Israel Adenosine Deaminase Deficiency Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. GCC Countries Adenosine Deaminase Deficiency Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Leadiant Biosciences Revenue Growth Rate in Adenosine Deaminase Deficiency Business (2019-2024)
    Figure 56. Chiesi Revenue Growth Rate in Adenosine Deaminase Deficiency Business (2019-2024)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed